Powered by

Tyme Technologies, Inc. to Present at the Evercore ISI, HealthconX Conference on November 27th

Nov 20, 2018 - GlobeNewswire

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will be featured as a presenting company at the Evercore ISI, HealthconX Conference.  The conference is being held on November 27 -29, 2018 at the Boston Harbor Hotel in Boston, MA.

Dr. Jonathan Eckard, Chief Scientific Affairs Officer, and Ben Taylor, President and Chief Financia...